Protein kinase Cζ regulates Cdk5/p25 signaling during myogenesis

Molecular Biology of the Cell

Volumn 21, Issue 8, 2010, Pages 1423-1434

  De Thonel, Aurélie ^a,b   Ferraris, Saima E ^a,b   Pallari, Hanna Mari ^a   Imanishi, Susumu Y ^a,b   Kochin, Vitaly ^a,b   Hosokawa, Tomohisa ^c   Hisanaga, Shin Ichi ^c   Sahlgren, Cecilia ^a,b   Eriksson, John E ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c TOKYO METROPOLITAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CYCLIN DEPENDENT KINASE 5; NESTIN; PROTEIN KINASE C ZETA; PROTEIN P25; PROTEIN P35; CDK5 PROTEIN, MOUSE; CDK5R PROTEIN, MOUSE; INTERMEDIATE FILAMENT PROTEIN; NERVE PROTEIN; PHOSPHOTRANSFERASE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN COS7; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; INTERMEDIATE FILAMENT; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL STRAIN COS1; CERCOPITHECUS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING; UPREGULATION;

ANIMALS; CALPAIN; CELL DIFFERENTIATION; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASE 5; INTERMEDIATE FILAMENT PROTEINS; MICE; MODELS, BIOLOGICAL; MUSCLE DEVELOPMENT; MYOBLASTS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 77950875199     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-10-0847     Document Type: Article

References (66)

1. Barnoy, S., Glaser, T., and Kosower, N. S. (1998). The calpain-calpastatin system and protein degradation in fusing myoblasts. Biochim. Biophys. Acta 1402, 52-60.
2. Barnoy, S., Maki, M., and Kosower, N. S. (2005). Overexpression of calpastatin inhibits L8 myoblast fusion. Biochem. Biophys. Res. Commun. 332, 697-701.
3. Berra, E., Diaz-Meco, M. T., Dominguez, I., Municio, M. M., Sanz, L., Lozano, J., Chapkin, R. S., and Moscat, J. (1993). Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell 74, 555-563. (Pubitemid 23244620)
4. Castellani, L., Salvati, E., Alema, S., and Falcone, G. (2006). Fine regulation of RhoA and Rock is required for skeletal muscle differentiation. J. Biol. Chem. 281, 15249-15257.
5. Cheung, Z. H., and Ip, N. Y. (2004). Cdk5, mediator of neuronal death and survival. Neurosci. Lett. 361, 47-51 [Review].
6. Cicero, S., and Herrup, K. (2005). Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. J. Neurosci. 25, 9658-9668. (Pubitemid 41510906)
7. Coleman, E. S., and Wooten, M. W. (1994). Nerve growth factor-induced differentiation of PC12 cells employs the PMA-insensitive protein kinase C-zeta isoform. J. Mol. Neurosci. 5, 39-57.
8. Cruz, J. C., and Tsai, L. H. (2004). A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease. Curr. Opin. Neurobiol. 14, 390-394, Review.
9. Dargelos, E., Dedieu, S., Moyen, C., Poussard, S., Veschambre, P., Brustis, J. J., and Cottin, P. (2002). Characterization of the calcium-dependent proteolytic system in a mouse muscle cell line. Mol. Cell Biochem. 231, 147-154.
10. Dhavan, R., and Tsai, L. H. (2001). A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2, 749-759 [Review].
11. Dourdin, N., Balcerzak, D., Brustis, J. J., Poussard, S., Cottin, P., and Ducastaing, A. (1999). Potential m-calpain substrates during myoblast fusion. Exp. Cell Res. 246, 433-442.
12. Eichholtz, T., de Bont, D. B., de Widt, J., Liskamp, R. M., and Ploegh, H. L. (1993). A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J. Biol. Chem. 268, 1982-1986.
13. Etienne-Manneville, S., and Hall, A. (2001). Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 106, 489-498. (Pubitemid 32786992)
14. Fernando, P., Kelly, J. F., Balazsi, K., Slack, R. S., and Megeney, L. A. (2002). Caspase 3 activity is required for skeletal muscle differentiation. Proc. Natl. Acad. Sci. USA 99, 11025-11030.
15. Fischer, A., Sananbenesi, F., Pang, P. T., Lu, B., and Tsai, L. H. (2005). Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 48, 825-838. (Pubitemid 41759432)
16. Fishelevich, R., Malanina, A., Luzina, I., Atamas, S., Smyth, M. J., Porcelli, S. A., and Gaspari, A. A. (2006). Ceramide-dependent regulation of human epidermal keratinocyte CD1d expression during terminal differentiation. J. Immunol. 176, 2590-2599. (Pubitemid 43201711)
17. Fu, A. K., Fu, W. Y., Cheung, J., Tsim, K. W., Ip, F. C., Wang, J. H., and Ip, N. Y. (2001). Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat. Neurosci. 4, 374-381.
18. Gao, L., Joberty, G., and Macara, I. G. (2002). Assembly of epithelial tight junctions is negatively regulated by Par6. Curr. Biol. 12(3), 221-225.
19. Guo, H., Gu, F., Li, W., Zhang, B., Niu, R., Fu, L., Zhang, N., and Ma, Y. (2009). Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells. J. Neurochem. 109, 203-213.
20. Hirai, T., and Chida, K. (2003). Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J. Biochem. 133, 1-7 [Review]. (Pubitemid 36240972)
21. Hofmann, J. (1997). The potential for isoenzyme-selective modulation of protein kinase C. FASEB J. 11, 649-669 [Review].
22. Kamei, H., Saito, T., Ozawa, M., Fujita, Y., Asada, A., Bibb, J. A., Saido, T. C., Sorimachi, H., and Hisanaga, S. (2007). Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation. J. Biol. Chem. 282, 1687-1694.
23. Kochin, V., Imanishi, S. Y., and Eriksson, J. E. (2006). Fast track to a phosphoprotein sketch - MALDI-TOF characterization of TLC-based tryptic phosphopeptide maps at femtomolar detection sensitivity. Proteomics 6, 5676-5682. (Pubitemid 44764004)
24. Kulkarni, S., Goll, D. E., and Fox, J. E. (2002). Calpain cleaves RhoA generating a dominant-negative form that inhibits integrin-induced actin filament assembly and cell spreading. J. Biol. Chem. 277, 24435-24441.
25. Kusakawa, G., Saito, T., Onuki, R., Ishiguro, K., Kishimoto, T., and Hisanaga, S. (2000). Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J. Biol. Chem. 275, 17166-17172.
26. Lazaro, J. B., Kitzmann, M., Poul, M. A., Vandromme, M., Lamb, N. J., and Fernandez, A. (1997). Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J. Cell Sci. 110, 1251-1260. (Pubitemid 27254399)
27. Lee, M. S., Kwon, Y. T., Li, M., Peng, J., Friedlander, R. M., and Tsai, L. H. (2000). Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364. (Pubitemid 30337070)
28. Leitges, M., Sanz, L., Martin, P., Duran, A., Braun, U., García, J. F., Camacho, F., Diaz-Meco, M. T., Rennert, P. D., and Moscat, J. (2001). Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol. Cell 8, 771-780. (Pubitemid 33030211)
29. Lew, J., Qi, Z., Huang, Q. Q., Paudel, H., Matsuura, I., Matsushita, M., Zhu, X., and Wang, J. H. (1995). Structure, function, and regulation of neuronal Cdc2-like protein kinase. Neurobiol. Aging 16, 263-268.
30. Liang, Y. C., Yeh, J. Y., Forsberg, N. E., and Ou, B. R. (2006). Involvement of mu- and m-calpains and protein kinase C isoforms in L8 myoblast differentiation. Int. J. Biochem. Cell Biol. 38, 662-670.
31. Liu, Q., Ning, W., Dantzer, R., Freund, G. G., and Kelley, K. W. (1998). Activation of protein kinase C-zeta and phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor-I. J. Immunol. 160, 1393-1401. (Pubitemid 28093440)
32. Mansat de Mas, V., de Thonel, A., Gaulin, V., Demur, C., Laurent, G., and Quillet-Mary, A. (2002). Protein kinase C-zeta overexpression induces erythroid phenotype in the monocytic leukaemia cell line U937. Br. J. Haematol. 118, 646-653.
33. Miyamoto, Y., Yamauchi, J., Chan, J. R., Okada, A., Tomooka, Y., Hisanaga, S., and Tanoue, A. (2007). Cdk5 regulates differentiation of oligodendrocyte precursor cells through the direct phosphorylation of paxillin. J. Cell Sci. 120, 4355-4366.
34. Neri, L. M., Martelli, A. M., Borgatti, P., Colamussi, M. L., Marchisio, M., and Capitani, S. (1999). Increase in nuclear phosphatidylinositol 3-kinase activity and phosphatidylinositol (3,4,5) trisphosphate synthesis precede PKC-zeta translocation to the nucleus of NGF-treated PC12 cells. FASEB J. 13, 2299-22310.
35. Nguyen, C., Hosokawa, T., Kuroiwa, M., Ip, N. Y., Nishi, A., Hisanaga, S., and Bibb, J. A. (2007). Differential regulation of the Cdk5-dependent phosphorylation sites of inhibitor-1 and DARPP-32 by depolarization. J. Neurochem. 103, 1582-1593. (Pubitemid 47631820)
36. Nishizuka, Y. (1995). Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 7, 484-496 [Review].
37. O'Hare, M. J., Kushwaha, N., Zhang, Y., Aleyasin, H., Callaghan, S. M., Slack, R. S., Albert, P. R., Vincent, I., and Park, D. S. (2005). Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excito-toxic neuronal death. J. Neurosci. 25, 8954-8966. (Pubitemid 41384464)
38. Olsen, J. V., de Godoy, L.M.F., Li, G., Macek, B., Mortensen, P., Pesch, R., Makarov, A., Lange, O., Horning, S., and Mann, M. (2005). Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell. Proteom. 4, 2010-2021.
39. Patrick, G. N., Zhou, P., Kwon, Y. T., Howley, P. M., and Tsai, L. H. (1998). p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J. Biol. Chem. 273, 24057-24064.
40. Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., and Tsai, L. H. (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622. (Pubitemid 129516324)
41. Philpott, A., Porro, E. B., Kirschner, M. W., and Tsai, L. H. (1997). The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev. 11, 1409-1421. (Pubitemid 27259852)
42. Rosales, J., Han, B., and Lee, K. Y. (2003). Cdk7 functions as a cdk5 activating kinase in brain. Cell Physiol. Biochem. 13, 285-296.
43. Sahlgren, C. M., Mikhailov, A., Vaittinen, S., Pallari, H. M., Kalimo, H., Pant, H. C., and Eriksson, J. E. (2003). Cdk5 regulates the organization of Nestin and its association with p35. Mol. Cell. Biol. 23, 5090-5106.
44. Sahlgren, C. M., Pallari, H. M., He, T., Chou, Y. H., Goldman, R. D., and Eriksson, J. E. (2006). A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death. EMBO J. 25, 4808-4819. (Pubitemid 44607026)
45. Sakaue, F., Saito, T., Sato, Y., Asada, A., Ishiguro, K., Hasegawa, M., and Hisanaga, S. (2005). Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39. J. Biol. Chem. 280, 31522-31529.
46. Saito, T., Onuki, R., Fujita, Y., Kusakawa, G., Ishiguro, K., Bibb, J. A., Kishimoto, T., and Hisanaga, S. (2003). Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation. J. Neurosci. 25, 8954-8966. (Pubitemid 36258898)
47. Sasaki, Y., et al. (2002). Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 35, 907-920.
48. Sato, K., Zhu, Y. S., Saito, T., Yotsumoto, K., Asada, A., Hasegawa, M., and Hisanaga, S. (2007). Regulation of membrane association and kinase activity of Cdk5-p35 by phosphorylation of p35. J. Neurosci. Res. 85, 3071-3078.
49. Schnack, C., Hengerer, B., and Gillardon, F. (2008). Identification of novel substrates for Cdk5 and new targets for Cdk5 inhibitors using high-density protein microarrays. Proteomics 8, 1980-1986. (Pubitemid 351775778)
50. Schroeder, M. J., Shabanowitz, J., Schwartz, J. C., Hunt, D. F., and Coon, J. J. (2004). A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry. Anal. Chem. 76, 3590-3598.
51. Seo, H. R., Kim, J., Bae, S., Soh, J. W., and Lee, Y. S. (2008). Cdk5-mediated phosphorylation of c-Myc on Ser-62 is essential in transcriptional activation of cyclin B1 by cyclin G1. J. Biol. Chem. 283, 15601-15610.
52. Shelton, S. B., and Johnson, G. V. (2004). Cyclin-dependent kinase-5 in neurodegeneration. J. Neurochem. 88, 1313-1326, Review.
53. Smith, P. D., Mount, M. P., Shree, R., Callaghan, S., Slack, R. S., Anisman, H., Vincent, I., Wang, X., Mao, Z., and Park, D. S. (2006). Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J. Neurosci. 26, 440-447. (Pubitemid 43237108)
54. Sorimachi, H., Imajoh-Ohmi, S., Emori, Y., Kawasaki, H., Ohno, S., Minami, Y., and Suzuki, K. (1989). Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m and mu-types. Specific expression of the mRNA in skeletal muscle. J. Biol. Chem. 264, 20106-20111.
55. Stewart, C. E., and Rittweger, J. (2006). Adaptive processes in skeletal muscle: molecular regulators and genetic influences. J. Musculoskelet. Neuronal. Interact. 6, 73-86 [Review].
56. Suzuki, A., Yamanaka, T., Hirose, T., Manabe, N., Mizuno, K., Shimizu, M., Akimoto, K., Izumi, Y., Ohnishi, T., and Ohno, S. (2001). Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J. Cell Biol. 52, 1183-1196. (Pubitemid 34280176)
57. Suzuki, A., Akimoto, K., and Ohno, S. (2003). Protein kinase C lambda/iota (PKClambda/iota): a PKC isotype essential for the development of multicellular organisms. J. Biochem. 133(1), 9-16 [Review]. (Pubitemid 36240973)
58. Ways, D. K., Posekany, K., deVente, J., Garris, T., Chen, J., Hooker, J., Qin, W., Cook, P., Fletcher, D., and Parker, P. (1994). Overexpression of protein kinase C-zeta stimulates leukemic cell differentiation. Cell Growth Differ. 5, 1195-1203.
59. Wei, F. Y., Nagashima, K., Ohshima, T., Saheki, Y., Lu, Y. F., Matsushita, M., Yamada, Y., Mikoshiba, K., Seino, Y., Matsui, H., and Tomizawa, K. (2005). Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nat. Med. 11, 1104-1108.
60. Wooten, M. W., Seibenhener, M. L., Neidigh, K. B., and Vandenplas, M. (2000). Mapping of atypical protein kinase C within the nerve growth factor signaling cascade: relationship to differentiation and survival of PC12 cells. Mol. Cell. Biol. 20, 4494-4504.
61. Wooten, M. W., Seibenhener, M. L., Mamidipudi, V., Diaz-Meco, M. T., Barker, P. A., and Moscat, J. (2001). The atypical protein kinase C interacting protein p62 is a scaffold for NFkB. J. Biol. Chem. 276, 7709-7712.
62. Xu, L., and Deng, X. (2006). Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains. J. Biol. Chem. 281, 4457-4466.
63. Yamada, M., Saito, T., Sato, Y., Kawai, Y., Sekigawa, A., Hamazumi, Y., Asada, A., Wada, M., Doi, H., and Hisanaga, S. (2007). Cdk5-p39 is a labile complex with the similar substrate specificity to Cdk5-p35. J. Neurochem. 102, 1477-1487. (Pubitemid 47256187)
64. Zhang, J., Cicero, S. A., Wang, L., Romito-Digiacomo, R. R., Yang, Y., and Herrup, K. (2008). Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc. Natl. Acad. Sci. USA 105, 8772-8777.
65. Zhou, G., Seibenhener, M. L., and Wooten, M. W. (1997). Nucleolin is a protein kinase C-zeta substrate. Connection between cell surface signaling and nucleus in PC12 cells. J. Biol. Chem. 272, 31130-31137.
66. Zukerberg, L. R., Patrick, G. N., Nikolic, M., Humbert, S., Wu, C. L., Lanier, L. M., Gertler, F. B., Vidal, M., Van Etten, R. A., and Tsai, L. H. (2000). Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase up-regulation, and neurite outgrowth. Neuron 26, 633-634.